The results demonstrated that the expression levels of CCNE1, E2F1, ARHGAP11A, RUNX1T1 and FES displayed significant correlation with the tumor stage in patients with NSCLC (Supplementary Figures S5A–E). This evidence concerns the gene FES and non-small cell lung carcinoma.